Effects of Canagliflozin in Patients with Baseline Egfr &lt;30 Ml/min Per 1.73 M<sup>2</sup>: Subgroup Analysis of the Randomized Credence Trial

Effects of Canagliflozin in Patients with Baseline Egfr <30 Ml/min Per 1.73 M<sup>2</sup>: Subgroup Analysis of the Randomized Credence Trial

Journal article published in 2020 by David Charytan

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload